Kala Bio (KALA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.19, -1.09% vs the prior close of $0.19.
- Volume 286.70K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KALA dips 1.1% to $0.19. Closed at $0.19, -1.09% vs the prior close of $0.19. Day range $0.18–$0.20, opened at $0.20.
KALA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — KALA dips 1.1% to $0.19
- Closed at $0.19, -1.09% vs the prior close of $0.19. Day range $0.18–$0.20, opened at $0.20.
- Volume was 286.70K shares, 0.2x its 50-day average of 1.89M — lighter than usual.
- Price is -67.1% vs its 50-day average ($0.58) and -97.7% vs its 200-day average ($8.36).
- 52-week range $0.12–$95.50; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 15, 2026 — KALA rises 2.1% to $0.19
- Closed at $0.19, +2.13% vs the prior close of $0.19. Day range $0.17–$0.20, opened at $0.19.
- Volume was 857.80K shares, 0.5x its 50-day average of 1.87M — lighter than usual.
- Price is -67.3% vs its 50-day average ($0.59) and -97.7% vs its 200-day average ($8.50).
- 52-week range $0.12–$95.50; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 14, 2026 — KALA slides 27.7% to $0.19, a 52-week low, 6 down days in a row
- Closed at $0.19, -27.69% vs the prior close of $0.26. Day range $0.12–$0.26, opened at $0.26.
- Volume was 1.67M shares, 0.9x its 50-day average of 1.84M.
- Price is -68.6% vs its 50-day average ($0.60) and -97.8% vs its 200-day average ($8.65).
- 52-week range $0.12–$95.50; today's close sits at 0% of that range, 99.8% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — KALA slides 7.1% to $0.26, a 52-week low, 5 down days in a row
- Closed at $0.26, -7.14% vs the prior close of $0.28. Day range $0.26–$0.28, opened at $0.28.
- Volume was 425.20K shares, 0.2x its 50-day average of 1.83M — lighter than usual.
- Price is -57.3% vs its 50-day average ($0.61) and -97.0% vs its 200-day average ($8.81).
- 52-week range $0.26–$95.50; today's close sits at 0% of that range, 99.7% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — KALA slides 4.8% to $0.28, a 52-week low, 4 down days in a row
- Closed at $0.28, -4.76% vs the prior close of $0.29. Day range $0.28–$0.30, opened at $0.28.
- Volume was 380.80K shares, 0.2x its 50-day average of 1.82M — lighter than usual.
- Price is -54.8% vs its 50-day average ($0.62) and -96.9% vs its 200-day average ($8.97).
- 52-week range $0.28–$95.50; today's close sits at 0% of that range, 99.7% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — KALA dips 1.0% to $0.29, a 52-week low, 3 down days in a row
- Closed at $0.29, -1.01% vs the prior close of $0.30. Day range $0.29–$0.30, opened at $0.30.
- Volume was 285.10K shares, 0.2x its 50-day average of 1.82M — lighter than usual.
- Price is -53.3% vs its 50-day average ($0.63) and -96.8% vs its 200-day average ($9.11).
- 52-week range $0.29–$95.50; today's close sits at 0% of that range, 99.7% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — KALA slides 17.5% to $0.30, a 52-week low
- Closed at $0.30, -17.50% vs the prior close of $0.36. Day range $0.29–$0.35, opened at $0.35.
- Volume was 655.50K shares, 0.4x its 50-day average of 1.81M — lighter than usual.
- Price is -53.4% vs its 50-day average ($0.64) and -96.8% vs its 200-day average ($9.25).
- 52-week range $0.29–$95.50; today's close sits at 0% of that range, 99.7% below the 52-week high.
Oct 7, 2026 — KALA dips 1.1% to $0.36, a 52-week low
- Closed at $0.36, -1.10% vs the prior close of $0.36. Day range $0.34–$0.40, opened at $0.37.
- Volume was 654.40K shares, 0.4x its 50-day average of 1.80M — lighter than usual.
- Price is -44.2% vs its 50-day average ($0.65) and -96.2% vs its 200-day average ($9.41).
- 52-week range $0.34–$95.50; today's close sits at 0% of that range, 99.6% below the 52-week high.
Oct 6, 2026 — KALA ends flat (+0.3%) to $0.36
- Closed at $0.36, +0.28% vs the prior close of $0.36. Day range $0.34–$0.39, opened at $0.35.
- Volume was 418.00K shares, 0.2x its 50-day average of 1.79M — lighter than usual.
- Price is -44.1% vs its 50-day average ($0.65) and -96.2% vs its 200-day average ($9.55).
- 52-week range $0.34–$95.50; today's close sits at 0% of that range, 99.6% below the 52-week high.
Oct 5, 2026 — KALA slides 5.7% to $0.36, a 52-week low, 4 down days in a row
- Closed at $0.36, -5.71% vs the prior close of $0.38. Day range $0.35–$0.39, opened at $0.39.
- Volume was 1.08M shares, 0.6x its 50-day average of 1.77M.
- Price is -44.8% vs its 50-day average ($0.66) and -96.3% vs its 200-day average ($9.70).
- 52-week range $0.35–$95.50; today's close sits at 0% of that range, 99.6% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — KALA slides 8.1% to $0.38, a 52-week low, 3 down days in a row
- Closed at $0.38, -8.11% vs the prior close of $0.42. Day range $0.38–$0.42, opened at $0.41.
- Volume was 1.08M shares, 0.6x its 50-day average of 1.75M.
- Price is -41.9% vs its 50-day average ($0.66) and -96.1% vs its 200-day average ($9.83).
- 52-week range $0.38–$95.50; today's close sits at 0% of that range, 99.6% below the 52-week high.
- That makes 3 straight losses.
KALA latest news & SEC filings
Every SEC filing by or about KALA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 24, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 11, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.08 — Set shareholder nomination dates.
- Item 8.01 — Reported other events the company considers important.
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Aug 19, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.58M (prior year -$11.15M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$21.32 (prior year -$85.64) (loss narrowed vs Jun 30, 2025)
Aug 14, 2026 · Form NT 10-Q — Notice of late quarterly report
Notice of late quarterly report
Jul 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 22, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 2, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 25, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Things to know before you trade KALA
- Last results release: Aug 8, 2025 (8-K Item 2.02). Previous ones: May 14, 2025, Mar 31, 2025, Nov 12, 2024. Based on that rhythm, the next report is likely around Nov 7, 2025 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 7.16% (largest 27.7%). That is a volatile stock.
- Liquidity: about 3.93M shares (≈$746.89K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.19 vs a range of $0.12–$95.50 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:50 on May 11, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Mary Reumuth sold 967 shares on Oct 23, 2025.
- Latest filings: 8-K Sep 10, 2026; 8-K Sep 9, 2026; 8-K Aug 28, 2026.
- Share count: 19.34M shares outstanding (Aug 14, 2026), +175.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
KALA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.20 | 0.20 | 0.18 | 0.19 | 286.70K |
| Oct 15, 2026 | 0.19 | 0.20 | 0.17 | 0.19 | 857.80K |
| Oct 14, 2026 | 0.26 | 0.26 | 0.12 | 0.19 | 1.67M |
| Oct 13, 2026 | 0.28 | 0.28 | 0.26 | 0.26 | 425.20K |
| Oct 12, 2026 | 0.28 | 0.30 | 0.28 | 0.28 | 380.80K |
| Oct 9, 2026 | 0.30 | 0.30 | 0.29 | 0.29 | 285.10K |
| Oct 8, 2026 | 0.35 | 0.35 | 0.29 | 0.30 | 655.50K |
| Oct 7, 2026 | 0.37 | 0.40 | 0.34 | 0.36 | 654.40K |
| Oct 6, 2026 | 0.35 | 0.39 | 0.34 | 0.36 | 418.00K |
| Oct 5, 2026 | 0.39 | 0.39 | 0.35 | 0.36 | 1.08M |
| Oct 2, 2026 | 0.41 | 0.42 | 0.38 | 0.38 | 1.08M |
| Oct 1, 2026 | 0.42 | 0.46 | 0.41 | 0.42 | 1.62M |
| Sep 30, 2026 | 0.52 | 0.54 | 0.41 | 0.43 | 29.43M |
| Sep 29, 2026 | 0.41 | 0.54 | 0.40 | 0.50 | 37.93M |
| Sep 28, 2026 | 0.46 | 0.49 | 0.43 | 0.45 | 576.30K |
| Sep 25, 2026 | 0.55 | 0.55 | 0.47 | 0.48 | 358.80K |
| Sep 24, 2026 | 0.53 | 0.57 | 0.52 | 0.56 | 684.60K |
| Sep 23, 2026 | 0.58 | 0.59 | 0.56 | 0.56 | 83.00K |
| Sep 22, 2026 | 0.57 | 0.61 | 0.55 | 0.60 | 134.40K |
| Sep 21, 2026 | 0.57 | 0.58 | 0.54 | 0.56 | 51.40K |
About Kala Bio
Kala Bio (KALA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ARLINGTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1479419.
KALA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Todd Bazemore | Director | Oct 24, 2025 |
| Chaim D. Berger | Director | Feb 9, 2026 |
| Yonatan C. Colman | Director | Feb 9, 2026 |
| Mark T Iwicki | Director | Oct 24, 2025 |
| David E. Lazar | Chief Executive Officer | Dec 22, 2025 |
| Avraham Minkowitz | Chief Executive Officer | Feb 9, 2026 |
| Hillel D. Posen | Director | Feb 9, 2026 |
| Brendan P. Purdy | Director | Feb 9, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Romulus K Brazzell | SEE REMARKS | Oct 24, 2025 |
| Darius Kharabi | CHIEF BUSINESS OFFICER | Oct 24, 2025 |
| David E. Lazar | Chief Executive Officer | Dec 22, 2025 |
| Avraham Minkowitz | Chief Executive Officer | Feb 9, 2026 |
| Mary Reumuth | CHIEF FINANCIAL OFFICER | Oct 24, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Oct 23, 2025 | Mary Reumuth | Sale | 967 | $0.82 |
| Oct 23, 2025 | Mary Reumuth | Sale | 967 | $0.82 |
| Oct 23, 2025 | Mary Reumuth | Sale | 967 | $0.82 |
| Oct 23, 2025 | Mary Reumuth | Sale | 967 | $0.82 |
| Oct 23, 2025 | Mark T Iwicki | Sale | 154,894 | $0.81 |
| Oct 23, 2025 | Mark T Iwicki | Sale | 154,894 | $0.81 |
| Oct 23, 2025 | Mark T Iwicki | Sale | 154,894 | $0.81 |
| Oct 23, 2025 | Mark T Iwicki | Sale | 154,894 | $0.81 |
| Oct 22, 2025 | Mary Reumuth | Sale | 32,230 | $0.83 |
| Oct 22, 2025 | Mary Reumuth | Sale | 32,230 | $0.83 |
| Oct 22, 2025 | Mary Reumuth | Sale | 32,230 | $0.83 |
| Oct 22, 2025 | Mary Reumuth | Sale | 32,230 | $0.83 |
| Oct 22, 2025 | Todd Bazemore | Sale | 47,768 | $0.83 |
| Oct 22, 2025 | Todd Bazemore | Sale | 47,768 | $0.83 |
| Oct 22, 2025 | Todd Bazemore | Sale | 47,768 | $0.83 |
KALA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-26.98M | -3.31 | $-31.99M |
| Dec 31, 2024 | — | $-38.51M | -10.15 | $-29.38M |
| Dec 31, 2023 | — | $-42.20M | -17.35 | $-27.93M |
| Dec 31, 2022 | — | $-44.82M | -29.48 | $-78.91M |
| Dec 31, 2021 | — | $-142.60M | -108.32 | $-108.23M |
Latest balance sheet: total assets $10.58M, total liabilities $1.54M, cash $229.00K (as of Jun 30, 2026).
KALA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 8, 2025 | 8-K Item 2.02 (results) | $369.00 |
| May 14, 2025 | 8-K Item 2.02 (results) | $163.50 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $286.50 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $354.50 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
| Aug 4, 2023 | 8-K Item 2.02 (results) | — |
| May 9, 2023 | 8-K Item 2.02 (results) | — |
| Mar 3, 2023 | 8-K Item 2.02 (results) | — |
| Nov 8, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on KALA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.